Nobilis RT+IBmulti+G+ND

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

العنصر النشط:

Infectious bronchitis virus strain M41; Infectious bronchitis virus strain 249g ; Avian rhinotracheitis virus strain But1 #8544 (subgroup A); Infectious bursal disease virus strain D78; Newcastle disease virus strain clone 30

متاح من:

Intervet Ireland Limited

ATC رمز:

QI01AA18

INN (الاسم الدولي):

Infectious bronchitis virus strain M41; Infectious bronchitis virus strain 249g ; Avian rhinotracheitis virus strain But1 #8544 (subgroup A); Infectious bursal disease virus strain D78; Newcastle disease virus strain clone 30

جرعة:

.

الشكل الصيدلاني:

Emulsion for injection

نوع الوصفة الطبية :

POM: Prescription Only Medicine as defined in relevant national legislation

المجموعة العلاجية:

Chickens

المجال العلاجي:

avian infectious bronchitis virus + newcastle disease virus / paramyxovirus + avian adenovirus + avian rhinotracheitis virus

الخصائص العلاجية:

Immunological - Inactivated Vaccine

الوضع إذن:

Authorised

تاريخ الترخيص:

2000-08-24

خصائص المنتج

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis RT+IBmulti+G+ND emulsion for injection for chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.5 ml dose contains:
ACTIVE SUBSTANCES:
Inactivated viral antigens of:
AMPV strain But1# 8544:
inducing

9.5 log
2
ELISA units*
IBV strain M41(Massachusetts):
inducing

5.5 log
2
VN units*
IBV strain 249g (D274/D207):
inducing

4.0 log
2
VN units*
IBDV strain D78:
inducing

14.5 log
2
VN units*
NDV strain Clone 30:
inducing

4.0 log
2
HI units per 1/50
th
dose*
or containing

50 PD
50
units
* serological response in chickens
ADJUVANT:
Liquid paraffin: 215 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
Polysorbate 80
Sorbitan mono-oleate
Glycine
Water for injections
White to nearly white oily emulsion.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Chickens (future breeders).
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Active immunisation of breeder chickens for:
-
reduction of infection and prevention of egg drop caused by the
Massachusetts serotype of infectious
bronchitis virus (IBV);
-
reduction of egg drop and eggshell defects caused by the D274/D207
serotype of infectious
bronchitis virus (IBV);
-
reduction of infection caused by Newcastle disease virus (NDV);
-
prevention of respiratory signs and reduction of egg drop and eggshell
defects related to avian
metapneumovirus (AMPV);
-
passive immunisation of the progeny of the vaccinated birds against
infectious bursal disease virus
(IBDV).
Onset of immunity:
•
IBV, NDV, AMPV: 4 weeks post-vaccination
•
IBDV in progeny: 1 day of age
Duration of immunity:
•
IBV, NDV, AMPV: one laying period
•
IBDV in progeny: 4 weeks
3.3
CONTRAINDICATIONS
None.
3.4
SPECIAL WARNINGS
Vaccinate healthy animals only.
3.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species:
Vaccination with inactivated vaccine will not completely prevent
shedding of wild type virus after
infection. Therefore, this vaccine is only meant to reduce the
clinical signs